Journal
Frontiers in Immunology
Publication Date
1-1-2023
Volume
14
First Page
1085893
Document Type
Open Access Publication
DOI
10.3389/fimmu.2023.1085893
Rights and Permissions
Wong S, Hamidi H, Costa LJ, Bekri S, Neparidze N, Vij R, Nielsen TG, Raval A, Sareen R, Wassner-Fritsch E and Cho HJ (2023) Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM. Front. Immunol. 14:1085893. doi: 10.3389/fimmu.2023.1085893 © 2023 Wong, Hamidi, Costa, Bekri, Neparidze, Vij, Nielsen, Raval, Sareen, Wassner-Fritsch and Cho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Wong, Sandy; Hamidi, Habib; Costa, Luciano J; Bekri, Selma; Neparidze, Natalia; Vij, Ravi; Nielsen, Tina G; Raval, Aparna; Sareen, Rajan; Wassner-Fritsch, Elisabeth; and Cho, Hearn J, "Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM." Frontiers in Immunology. 14, 1085893 (2023).
https://digitalcommons.wustl.edu/oa_4/2988
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
